Pfizer's Duffy: Job cuts not a result of high costs

The vice president of manufacturing for Pfizer has said the decision to scale back operations here was not based on the cost of doing business here.

Paul Duffy said the decision was driven by factors including flexibility of plants, technology and the recent merger with Weyth.